Home WebinarsAEM2-1107-Webinar Sidebar

AEM2-1107-Webinar Sidebar

WEBINAR

2D materials with a thickness of one nanometer or less can be used as single sheets or as building blocks for heterostructures and metamaterials, due to their unique properties and ability to (self)assemble into a variety of structures. Graphene is the best-known example, but numerous compounds, ranging from BN (white graphene) to MXenes, have been produced as 2D sheets. By combining various 2D materials, unique combinations of properties can be achieved which are not available in bulk materials. The versatile chemistry of the MXene family renders their properties tunable for a large variety of applications, complementing graphene, BN, and other 2D materials.

Key learning points:

What are 2D nanomaterials
Properties of 2D nanomaterials
Applications of 2D nanomaterials
The focus will be on MXenes and how they complement the array of available 2D materials (graphene, BN, TMDs, etc.)

Speakers

Adam Jakus, Ph.D.

Dimension Inx, LLC

Co-Founder and Chief Technology

Adam Jakus, Ph.D. is the co-founder and Chief Technology of Dimension Inx, LLC, a start-up developing transformative advanced manufacturing materials and processes for medical and non-medical spaces. Adam received his BS and MS degrees in Materials Science and Engineering from Georgia Tech, where he worked on the development and testing of new energetic material systems. In 2010, he began working at Northwestern University with Dimension Inx’s other co-founder, Ramille Shah, Ph.D. While at Northwestern, Adam invented and developed an entirely new, materials-centric approach to 3D-printing and advanced manufacturing, now referred to as 3D-Painting, and hundreds of new 3D-printable materials for medical and non-medical purposes. These materials include, but are not limited to the high tissue and organ regenerative Hyperelastic Bone™, 3D-Graphene, Tissue Papers, and Fluffy-X. With approximately 10 years and many thousands of hours of bioprinting and tissue regenerative 3D-Printing experience, Adam leads the field, providing expertise to several not-for-profit bodies looking to establish guidelines, guidance, and certifications related to the emerging fields of tissue and organ fabrication. He is the author of numerous granted and pending patents, high impact medical and non-medical publications, book chapters, and editorials related to advanced manufacturing and 3D-printing of biomaterials and non-materials.